Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $210,473 | $159,698 | $154,892 | $199,137 |
| % Growth | 31.8% | 3.1% | -22.2% | – |
| Cost of Goods Sold | $62,660 | $54,413 | $64,494 | $90,725 |
| Gross Profit | $147,813 | $105,285 | $90,398 | $108,412 |
| % Margin | 70.2% | 65.9% | 58.4% | 54.4% |
| R&D Expenses | $0 | $10,812 | $6,200 | $8,794 |
| G&A Expenses | $0 | $0 | $0 | $38,432 |
| SG&A Expenses | $0 | $35,322 | $35,095 | $60,169 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $21,737 |
| Other Operating Expenses | $71,499 | $31,223 | $26,084 | $6,502 |
| Operating Expenses | $71,499 | $77,357 | $67,379 | $75,465 |
| Operating Income | $76,314 | $27,928 | $23,019 | $32,947 |
| % Margin | 36.3% | 17.5% | 14.9% | 16.5% |
| Other Income/Exp. Net | -$618 | -$1,151 | -$170 | -$754 |
| Pre-Tax Income | $75,696 | $26,777 | $22,849 | $32,193 |
| Tax Expense | $17,685 | $5,153 | $4,773 | $8,800 |
| Net Income | $58,029 | $21,635 | $18,101 | $23,389 |
| % Margin | 27.6% | 13.5% | 11.7% | 11.7% |
| EPS | 1.13 | 0.42 | 0.35 | 1.81 |
| % Growth | 169% | 20% | -80.7% | – |
| EPS Diluted | 1.13 | 0.42 | 0.35 | 1.81 |
| Weighted Avg Shares Out | 51,145 | 51,145 | 51,145 | 51,125 |
| Weighted Avg Shares Out Dil | 51,145 | 51,145 | 51,145 | 51,125 |
| Supplemental Information | – | – | – | – |
| Interest Income | $86 | $139 | $568 | $233 |
| Interest Expense | $757 | $699 | $629 | $1,780 |
| Depreciation & Amortization | $7,469 | $3,712 | $7,281 | $322 |
| EBITDA | $83,922 | $31,080 | $30,145 | $32,691 |
| % Margin | 39.9% | 19.5% | 19.5% | 16.4% |